Look Sharpe, Says Goldman: Stocks That Thrive Amid Volatility Will Have a Good 2022
With slower economic growth and higher rates, these shares should handily outpace the S&P 500, the firm contends.
The biotech firm says its booster shot gives good protection against Omicron.
Exceeding 6% returns over the next decade will likely require excess risk or consistently performing well above average.
Commodities are starting to drop in price and new supply will ease housing costs, argues economist David Rosenberg.
The lawsuit claims the fitness company and its executives lied about the prospects of post-COVID growth.
Biden moves to take out 50 million barrels from storage, but petro price blips up.